Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Nov 19:76:e3528.
doi: 10.6061/clinics/2021/e3528. eCollection 2021.

COVID-19 and strongyloidiasis: what to expect from this coinfection?

Affiliations

COVID-19 and strongyloidiasis: what to expect from this coinfection?

Carolina Victoria Marcitelli Pereira et al. Clinics (Sao Paulo). .
No abstract available

PubMed Disclaimer

Conflict of interest statement

No potential conflict of interest was reported.

Figures

Figure 1
Figure 1. Timeline of the main events related to SARS-CoV-2 and S. stercoralis coinfections.

References

    1. Toledo R, Muãoz-Antoli C, Esteban JG. Strongyloidiasis with emphasis on human infections and its different clinical forms. Adv Parasitol. 2015;88:165–241. doi: 10.1016/bs.apar.2015.02.005. - DOI - PubMed
    1. Marty FM, Lowry CM, Rodriguez M, Milner DA, Pieciak WS, Sinha A, et al. Treatment of human disseminated strongyloidiasis with a parenteral veterinary formulation of ivermectin. Clin Infect Dis. 2005;41(1):e5–e8. doi: 10.1086/430827. - DOI - PubMed
    1. Formiga FR, Leblanc R, de Souza Rebouças J, Farias LP, de Oliveira RN, Pena L. Ivermectin: an award-winning drug with expected antiviral activity against COVID-19. J Control Release. 2021;329:758–61. doi: 10.1016/j.jconrel.2020.10.009. - DOI - PMC - PubMed
    1. Tilli M, Olliaro P, Gobbi F, Bisoffi Z, Bartoloni A, Zammarchi L. Neglected tropical diseases in non-endemic countries in the era of COVID-19 pandemic: the greath forgotten. J Travel Med. 2021;28(1):taaa179. doi: 10.1093/jtm/taaa179. - DOI - PMC - PubMed
    1. De Wilton A, Nabarro LE, Godbole GS, Chiodini PL, Boyd A, Woods K. Risk of Strongyloides Hyperinfection Syndrome when prescribing dexamethasone in severe COVID-19. Travel Med Infect Dis. 2021;40:101981. doi: 10.1016/j.tmaid.2021.101981. - DOI - PMC - PubMed